4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-016029
Options or other derivatives
- CSO, Head Res.&Non-Clin. Dev. acquired 48,368 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kavanaugh William Michael · CSO, Head Res.&Non-Clin. Dev.
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-04-14 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +48,368 | 96,736 | D |
Loading xslF345X03/doc1.xml…